000 02312 a2200649 4500
005 20250515131909.0
264 0 _c20081211
008 200812s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2008.207
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcCubrey, J A
245 0 0 _aInvolvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.
_h[electronic resource]
260 _bLeukemia
_cNov 2008
300 _a2080-90 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnnexin A5
_xmetabolism
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBlotting, Western
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aCysteine Proteinase Inhibitors
_xpharmacology
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aExtracellular Signal-Regulated MAP Kinases
_xantagonists & inhibitors
650 0 4 _aGenes, Dominant
650 0 4 _aHematopoietic Stem Cells
_xdrug effects
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aLeupeptins
_xpharmacology
650 0 4 _aMice
650 0 4 _aMitogen-Activated Protein Kinase Kinases
_xantagonists & inhibitors
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-mdm2
_xantagonists & inhibitors
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTumor Suppressor Protein p53
_xantagonists & inhibitors
650 0 4 _araf Kinases
_xantagonists & inhibitors
700 1 _aAbrams, S L
700 1 _aLigresti, G
700 1 _aMisaghian, N
700 1 _aWong, E W T
700 1 _aSteelman, L S
700 1 _aBäsecke, J
700 1 _aTroppmair, J
700 1 _aLibra, M
700 1 _aNicoletti, F
700 1 _aMolton, S
700 1 _aMcMahon, M
700 1 _aEvangelisti, C
700 1 _aMartelli, A M
773 0 _tLeukemia
_gvol. 22
_gno. 11
_gp. 2080-90
856 4 0 _uhttps://doi.org/10.1038/leu.2008.207
_zAvailable from publisher's website
999 _c18160191
_d18160191